 MINNEAPOLIS, Sept. 17, 2021 GLOBE NEWSWIRE -- CVRx, Inc. NASDAQ: CVRX CVRx, a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases, today announced it will be added as a member of the Russell 2000 and 3000 Indexes, effective after the U.S. market opens on September 20, as part of the Russells quarterly additions of select initial public offering IPO companies. 